Whether cancer-associated mutations in SIGLEC12 or its variants found in the general population play an important part in the pathogenesis of human diseases, such as sensitivity to infections, in which necroptosis has been implicated, remains to be determined. This evidence concerns the gene SIGLEC12 and infection.